is glp-1 semaglutide Another Weight-Loss Trial Win for Weekly Drug Hims Inc. - Hims &

There is also emerging research that weight loss drugs contribute to sarcopenia (loss of muscle) which is already an issue as we age and can cause issues later in life

described a transient increase of blood glucose levels as high as 518 mg/dL, occurring within 1 to 5 days after GS administration [59]

Low incidence of anti-drug antibodies in patients with type 2 diabetes treated with once-weekly glucagon-like peptide-1 receptor agonist dulaglutide

Both phentermine and semaglutide users may experience this

Avoid doubling doses, as this increases the risk of gastrointestinal adverse effects without improving efficacy